Trial Profile
A phase II trial of MSS-722 for the treatment of secondary hypogonadism
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 04 Feb 2016
Price :
$35
*
At a glance
- Drugs Clomifene (Primary)
- Indications Hypogonadism
- Focus Therapeutic Use
- 04 Feb 2016 New trial record